DRI Healthcare Trust (TSE:DHT) Rating Lowered to Moderate Buy at Raymond James

DRI Healthcare Trust (TSE:DHT) was downgraded by analysts at Raymond James from a “strong-buy” rating to a “moderate buy” rating in a research report issued to clients and investors on Monday, Zacks.com reports.

Separately, Scotiabank upgraded DRI Healthcare Trust to a “strong-buy” rating in a research note on Friday, June 14th.

DRI Healthcare Trust Stock Performance

DRI Healthcare Trust (TSE:DHT) last posted its quarterly earnings results on Monday, May 6th. The company reported C$0.57 EPS for the quarter, missing analysts’ consensus estimates of C$0.66 by C($0.09). The company had revenue of C$56.71 million during the quarter, compared to analyst estimates of C$55.13 million.

Insider Buying and Selling at DRI Healthcare Trust

In related news, insider DRI Capital Inc. bought 75,000 shares of the firm’s stock in a transaction on Wednesday, May 8th. The stock was bought at an average cost of C$11.95 per share, for a total transaction of C$896,250.00.

About DRI Healthcare Trust

DHT is an independent crude oil tanker company. Its fleet trades internationally and consists of crude oil tankers in the VLCC segment. It operates through its integrated management companies in Monaco, Singapore and Oslo, Norway. You shall recognize it by its business approach with an experienced organization with focus on first rate operations and customer service, quality ships built at quality shipyards, prudent capital structure with robust cash break even levels to accommodate staying power through the business cycles, a combination of market exposure and fixed income contracts for its fleet and a transparent corporate structure maintaining a high level of integrity and good governance.